Chronic Hepatitis C

Chronic Hepatitis C - most related articles:

- Hepatitis B hits men harder than women due to an abnormal protein - 7.8
- More cases of hepatitis D reported from Sabarkantha in Gujrat - 6.5
- Incivek for hepatitis C infection is approved in US - 6.2
- Hepatitis C declines health with liver disease - 6
- Positive results of Albuferon in Chronic Hepatitis C - 5.6
- HIV positive have good survival rate after liver transplant - 5.4
- New hope for hepatitis C sufferers - 4.9
- New biomarker predicts response to hepatitis C treatment - 4.4
- Obesity enhances liver cancer risk - 4.1
- Children with chronic daily headache may improve with time - 2.7

Chronic Hepatitis C articles

Incivek for hepatitis C infection is approved in US
The U.S. Food and Drug Administration approved Incivek (telaprevir) to treat certain adults with chronic hepatitis C infection. Incivek is used for patients who have either not received interferon-based drug therapy for their infection or who have not responded adequately to prior therapies.

Hepatitis B hits men harder than women due to an abnormal protein
Researchers are trying to explain the long-standing mystery of why the hepatitis B virus (HBV) sexually discriminates -- hitting men harder than women.

Positive results of Albuferon in Chronic Hepatitis C
Human Genome Sciences, Inc. (Nasdaq: HGSI) announced that Albuferon (albinterferon alfa-2b) met its primary endpoint of non-inferiority to peginterferon alfa-2a (Pegasys) in ACHIEVE 1, a Phase 3 clinical trial of Albuferon in combination with ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C (p=0.0008).

Hepatitis C declines health with liver disease
An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment.

4 Chronic Hepatitis C articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
3.55